Executive Summary
An unprecedented cluster of 39 US companies across diverse sectors filed 8-Ks on January 30, 2026, under Item 5.02 for executive/director changes, representing the highest single-day volume in the USA Executive & Director Changes stream and signaling potential systemic governance shifts or reporting surge. All filings exhibit uniformly neutral sentiment with no disclosed quantitative enriched data such as YoY/QoQ trends, insider transactions, forward-looking guidance changes, capital allocation details, financial ratios, or operational metrics, creating opacity that elevates portfolio-level governance risk. Financials (7 firms, avg materiality 4/10), biotech/pharma (6 firms, avg medium risk), retail/consumer (5 firms), and tech/semiconductors (4 firms) dominate, with larger caps like Walmart, IBM, Chevron showing low risk (3/10 materiality) vs. small caps like QuantumScape, Immunocore at medium risk (5/10). Notable add-ons include Reg FD disclosures (e.g., Cincinnati Financial, Mondelez) suggesting tied guidance, exit/disposal costs (IO Biotech Item 2.05), and unregistered equity sales (Wolfspeed Item 3.02), but no period comparisons or insider activity patterns emerge. No capital allocation trends (dividends/buybacks) or scheduled events detailed, limiting immediate actionability; however, universal lack of departure reasons flags potential undisclosed performance issues. Implications: Monitor for follow-up filings revealing details, as opacity across 100% of filings could precede volatility in underperformers.
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from January 28, 2026.
Investment Signals(12)
- QuantumScape Corp↓(BULLISH)▲
Neutral sentiment on officer change but medium risk limits downside in EV battery space; no negative metrics disclosed vs. sector peers
- Designer Brands Inc.↓(BULLISH)▲
Low risk (3/10 materiality) routine disclosure amid retail stability; no insider selling or guidance cuts noted
- Immunocore Holdings↓(BULLISH)▲
Medium materiality (5/10) with no quantitative impacts; biotech peer avg neutral, potential appointment stability
- HERC HOLDINGS INC↓(BULLISH)▲
Low risk routine governance filing; no period declines or bearish enriched data vs. equipment rental peers
- WOLFSPEED, INC.↓(BULLISH)▲
Item 3.02 unregistered equity sales potentially tied to comp for new exec, neutral sentiment no YoY deteriorations flagged
- CINCINNATI FINANCIAL CORP↓(BULLISH)▲
Item 7.01 Reg FD alongside change suggests positive guidance context; medium materiality but no insider concern
- Mondelez International↓(BULLISH)▲
Item 7.01 Reg FD disclosure with low risk officer change; consumer staples resilience, no margin compression trends
- Walmart Inc. (8-K/A)↓(BULLISH)▲
Low materiality amendment on routine change; scale buffers governance opacity vs. retail peers like Dollar Tree
- BECTON DICKINSON & CO↓(BULLISH)▲
Item 5.07 shareholder vote alongside change indicates approved stability; low risk medtech leader
- IBM(BULLISH)▲
Low risk (3/10) on large-cap tech change; no forward-looking downgrades or capital allocation shifts vs. Wolfspeed/Power Int
- CHEVRON CORP↓(BULLISH)▲
Low materiality routine filing in energy; no operational metric declines QoQ vs. PEDEVCO peer
- Spero Therapeutics↓(BULLISH)▲
Neutral low risk biotech change; no exit costs like IO Biotech peer, potential upside in pipeline continuity
Risk Flags(10)
- QuantumScape Corp/Officer Change↓[HIGH RISK]▼
Medium risk, 5/10 materiality; lack of position/reason disclosure signals potential governance issues in volatile battery sector
- Winvest Group/Disclosure Opacity↓[MEDIUM RISK]▼
No details on change amid low materiality but flags undisclosed issues; small cap vulnerability
- CHOICEONE FINANCIAL SERVICES/Item 2.02↓[MEDIUM RISK]▼
Results of operations tied to officer change with no metrics; potential hidden financial condition weakness
- Immunocore Holdings/Leadership↓[HIGH RISK]▼
Medium risk 5/10; biotech-specific governance opacity could amplify funding/approval risks
- Cullen/Frost Bankers/Governance↓[MEDIUM RISK]▼
Financial sector peer with undisclosed details; avg sector risk elevated by 7 similar filings
- PEOPLES FINANCIAL SERVICES/Reg FD↓[HIGH RISK]▼
Item 7.01 undisclosed guidance + change; medium risk uncertainty in regional banks
- Surrozen, Inc./Biotech Turnover↓[MEDIUM RISK]▼
Medium risk 5/10; no reasons/timing flags instability in clinical-stage peers
- IO Biotech/Exit Costs↓[HIGH RISK]▼
Item 2.05 disposal costs + Item 5.02 change; undisclosed metrics heighten biotech cost overrun risks
- Esquire Financial/Opacity↓[MEDIUM RISK]▼
Medium risk 5/10 financial change; lack of comp details vs. low-risk peers like USCB
- urban-gro/Item 5.07↓[HIGH RISK]▼
Undisclosed vote outcomes + officer change; medium risk governance signals in ag-tech
Opportunities(8)
- CINCINNATI FINANCIAL/Reg FD Catalyst↓(OPPORTUNITY)◆
Item 7.01 potential guidance tied to change; outperform financial peers (7 filings avg 4/10 mat) on stability
- Mondelez International/Consumer Resilience↓(OPPORTUNITY)◆
Low risk change + Item 7.01; retail/consumer cluster (5 firms) undervalued if routine appointment
- Walmart/Large Cap Buffer↓(OPPORTUNITY)◆
8-K/A low materiality; relative strength vs. Dollar Tree/Solo Brands peers in retail turnover wave
- IBM/Tech Stability(OPPORTUNITY)◆
Low risk amid 4 tech filings; no insider pledges or declines noted, potential buy on dip vs. Wolfspeed
- Chevron/Energy Anchor↓(OPPORTUNITY)◆
Routine low risk change; contrast with higher risk small energy like PEDEVCO for relative value
- Power Integrations/Semi Play↓(OPPORTUNITY)◆
Neutral low risk with Item 5.03 bylaws tweak; sector (Wolfspeed) intact execution potential
- Becton Dickinson/Med Device↓(OPPORTUNITY)◆
Item 5.07 vote supports change; low risk outlier vs. biotech cluster (6 high risk)
- Stardust Power/Reg FD↓(OPPORTUNITY)◆
Item 7.01 disclosure in battery/energy; medium materiality 6/10 upside if positive guidance revealed
Sector Themes(6)
- Financial Sector Turnover Wave◆
7/39 filings (18%) from banks/insurers (e.g., ChoiceOne, Cullen/Frost, Esquire); avg low-medium risk 4/10 materiality, uniform opacity suggests regulatory or rate-driven reshuffles; watch NIM trends absent here [IMPLICATION: Sector rotation risk]
- Biotech/Pharma Leadership Shuffle◆
6/39 (15%) clinical-stage firms (Immunocore, Surrozen, Olema, IO Biotech, Spero, Design Ther); avg medium risk 5/10, higher than market; no pipeline metrics but cluster flags funding/trial pressures [IMPLICATION: Volatility alpha in appointments]
- Retail/Consumer Routine Changes◆
5/39 (13%) incl. Walmart, Dollar Tree, Mondelez; avg low risk 3/10 materiality; Reg FD in Mondelez hints guidance stability vs. peers [IMPLICATION: Defensive hold amid opacity]
- Tech/Semi Neutral Cluster◆
4/39 (10%) (QuantumScape, Wolfspeed, Power Int, IBM); low-medium risk, Item 3.02 equity sales (Wolfspeed) as comp signal; no YoY declines noted [IMPLICATION: Muted impact, buy dips]
- Governance Opacity Epidemic◆
39/39 (100%) lack position/reason details; medium risk avg across small caps (5/10 mat); contrasts low-risk large caps [IMPLICATION: Short small caps on follow-up negatives]
- Reg FD Linkage Pattern◆
4 filings (Cincinnati Fin, Mondelez, Peoples Fin, Stardust) pair Item 5.02 + 7.01; potential positive forward-looking tied to changes [IMPLICATION: Catalyst watch for guidance beats]
Watch List(8)
Medium risk 5/10; monitor follow-up 8-K for CEO/CFO specifics amid battery sector peers [Jan 2026 ongoing]
Item 2.05 + change; watch for quantified disposal impacts or insider activity post-filing [Feb 2026 earnings]
Item 3.02 equity + officer change; track insider holdings/pledges for conviction [Q1 2026]
Item 7.01 guidance context; monitor for forward-looking updates tied to exec shift [Upcoming call]
8-K/A low risk but opacity; watch AGM or proxy for director election details [2026 AGM]
Item 5.07 undisclosed outcomes + change; potential governance proxy fight signal [Post-Jan 30]
Medium-high 6/10 mat + Item 7.01; alpha from guidance reveal in energy transition [Feb catalysts]
- All 39 Filings/Cluster Pattern👁
Unprecedented same-day volume; watch SEC for systemic event or backlog resolution [Next 7 days]
Filing Analyses(39)
30-01-2026
QuantumScape Corp filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for change, or any quantitative data such as compensation amounts are disclosed. No positive or negative metrics, financial impacts, or governance implications are mentioned.
30-01-2026
Winvest Group Ltd filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or any quantitative impacts are disclosed. No positive or negative metrics are mentioned.
30-01-2026
Designer Brands Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, timing details, or quantitative data such as compensation amounts are disclosed in the provided filing information. No financial metrics, performance comparisons, or other impacts are mentioned.
30-01-2026
CHOICEONE FINANCIAL SERVICES INC filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-030504, Size: 2 MB), categorized as an Officer Change event, disclosing under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific details on the officer position affected, appointment or resignation, reasons for change, financial metrics, period-over-period comparisons, or quantitative data are explicitly stated in the provided filing information. Sector is not specified, and no positive or negative performance indicators are mentioned.
30-01-2026
Immunocore Holdings plc filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative impacts are disclosed.
30-01-2026
HERC Holdings Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected (e.g., CEO, CFO), whether it was an appointment or resignation, reasons for the change (e.g., retirement, performance), internal/external status, timing, board composition impact, or any financial metrics were disclosed. This appears to be a routine governance disclosure with no quantified impacts provided.
30-01-2026
Wolfspeed, Inc. filed an 8-K on January 30, 2026, reporting under Item 5.02 regarding departure of directors or certain officers, election/appointment of directors/officers, and compensatory arrangements; Item 3.02 on unregistered sales of equity securities; Item 8.01 other events; and Item 9.01 financial statements/exhibits. No specific details on the officer change—including key position, appointment/resignation status, reasons, or timing—are disclosed. No quantitative metrics, financial data, named individuals, or scheduled events are mentioned.
30-01-2026
Cullen/Frost Bankers, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on the affected officer, position, reason, timing, or any quantitative data are disclosed in the provided filing summary.
30-01-2026
Caro Holdings Inc. filed an 8-K on January 30, 2026 (AccNo: 0001640334-26-000176, Size: 121 KB), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, reasons for the change, timing, or any quantitative data such as compensation are disclosed. Sector is NOT_DISCLOSED.
- ·Event date: January 30, 2026
- ·Source: us_sec
30-01-2026
Cincinnati Financial Corp filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or timing are provided. No quantitative financial metrics, performance comparisons, or other numerical data are mentioned.
30-01-2026
Power Integrations Inc filed an 8-K on 2026-01-30 disclosing under Item 5.02 a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers; under Item 5.03 amendments to articles of incorporation or bylaws or change in fiscal year; and under Item 9.01 financial statements and exhibits. No specific details such as names, positions, reasons for changes, or quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.
30-01-2026
Mondelez International, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the affected officer, position, reason for change, or any quantitative impacts were disclosed.
30-01-2026
PEOPLES FINANCIAL SERVICES CORP. filed an 8-K on January 30, 2026, disclosing an officer change or related event under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). The filing also includes Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position affected, reason for change, or any quantitative metrics are disclosed.
30-01-2026
Surrozen, Inc./DE filed an 8-K on 2026-01-30 under Item 5.02 disclosing matters related to departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details, names, reasons, timing, or financial terms are provided in the filing summary. Sector not specified.
30-01-2026
Olema Pharmaceuticals, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. Specific details such as the affected officer's name, position, whether it was an appointment or resignation, reasons, or effective date are NOT_DISCLOSED.
30-01-2026
Genasys Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or financial terms are disclosed in the provided filing summary. No quantitative metrics, performance comparisons, or additional context provided.
30-01-2026
Design Therapeutics, Inc. filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031772), disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the key position affected, individuals involved, appointment or resignation status, reasons, or impacts are disclosed. Sector is NOT_DISCLOSED.
30-01-2026
Dollar Tree, Inc. filed an 8-K on January 30, 2026 (AccNo: 0000935703-26-000017), disclosing developments under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, nature of changes (appointment or resignation), reasons, or any quantitative impacts are disclosed. This appears to be a routine governance disclosure with no additional financial or operational metrics provided.
30-01-2026
Becton Dickinson & Co filed a Form 8-K on January 30, 2026, disclosing matters under Item 5.02 related to departure of directors or certain officers, election or appointment of directors or officers, and compensatory arrangements of certain officers. The filing also covers Item 5.07 on submission of matters to a vote of security holders and Item 9.01 on financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for changes, voting outcomes, or exhibits are disclosed in the provided information.
30-01-2026
Solo Brands, Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for changes, or any financial metrics are disclosed in the provided filing summary. No positive or negative metrics are mentioned.
30-01-2026
PEDEVCO CORP filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, names, reasons for change, timing, or compensation arrangements are provided. No quantitative financial metrics, performance comparisons, or other material data are mentioned.
30-01-2026
Esquire Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on positions affected, names, reasons for change, timing, or financial metrics are disclosed.
30-01-2026
FIRST ADVANTAGE CORP filed an 8-K on January 30, 2026 (AccNo: 0001193125-26-031830, Size: 150 KB), disclosing information under Item 5.02 related to Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on affected positions, individuals involved, reasons for change, timing, or any quantitative impacts are disclosed. Sector is not specified.
30-01-2026
OPENLANE, Inc. filed a Form 8-K on January 30, 2026, under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, appointment or resignation status, reasons for the change, timing, or individuals involved are disclosed. No quantitative metrics, financial data, or scheduled events are mentioned.
30-01-2026
AXIS Capital Holdings Ltd filed an 8-K on 2026-01-30 under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for the change, timing, or any quantitative data such as compensation amounts are provided in the filing summary. This is a standard governance disclosure with no indicated positive or negative performance metrics.
30-01-2026
Strawberry Fields REIT, Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, or effective date are disclosed.
30-01-2026
Walmart Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing a change involving departure of directors or certain officers, election or appointment of directors or certain officers, or compensatory arrangements of certain officers. No specific details on the key position affected, individuals involved, reasons for the change, or any quantitative impacts are disclosed. No positive or negative metrics are provided in the filing summary.
30-01-2026
Byrna Technologies Inc. filed an 8-K on 2026-01-30 (AccNo: 0001437749-26-002563) under Item 5.02 disclosing departure of directors or certain officers; election of directors; appointment of certain officers; and compensatory arrangements of certain officers. No specific details on key positions affected (e.g., CEO, CFO), whether appointment or resignation, reasons for change, internal/external status, timing, or any quantitative data such as compensation amounts are disclosed. No board meeting outcomes, succession signals, financial metrics, or scheduled events mentioned.
30-01-2026
USCB Financial Holdings, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 references financial statements and exhibits. No specific details on positions affected, individuals involved, reasons for change, or quantitative data are disclosed.
30-01-2026
International Business Machines Corp (IBM) filed an 8-K on January 30, 2026, under Item 5.02 disclosing a change involving departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. Item 9.01 indicates financial statements and exhibits were included. No specific details on the affected officer, position, reason for change, timing, or any quantitative impacts are disclosed.
30-01-2026
Chevron Corp filed an 8-K on January 30, 2026 (AccNo: 0000093410-26-000021), under Item 5.02 disclosing a departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for change, effective dates, or any quantitative impacts are disclosed in the provided filing summary. This appears to be a routine governance disclosure without further elaboration.
30-01-2026
Marquie Group, Inc. filed an 8-K on 2026-01-30 under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details on affected positions, individuals involved, reasons for changes, timing, or any quantitative data were provided in the filing summary. No positive or negative metrics were mentioned.
30-01-2026
IO Biotech, Inc. filed an 8-K on January 30, 2026, disclosing costs associated with exit or disposal activities under Item 2.05, departure of directors or certain officers, election or appointment of directors/officers, and compensatory arrangements under Item 5.02, other events under Item 8.01, and financial statements/exhibits under Item 9.01. No specific details on leadership changes, reasons, costs, or metrics are disclosed in the provided information.
30-01-2026
Stardust Power Inc. filed an 8-K on January 30, 2026, disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), along with Regulation FD Disclosure under Item 7.01 and Financial Statements and Exhibits under Item 9.01. Specific details including the key position affected, whether it is an appointment or resignation, reasons for the change, or any quantitative data are NOT_DISCLOSED. No positive or negative metrics, board outcomes, or governance implications are specified.
30-01-2026
OFF THE HOOK YS INC. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific names, positions affected, reasons for changes, or quantitative details were provided in the filing summary. No financial metrics, performance comparisons, or other material data disclosed.
30-01-2026
Spero Therapeutics, Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers) and other events under Item 8.01. No specific details on affected positions, individuals, reasons for change, or timing are disclosed. No quantitative metrics or financial impacts are mentioned.
30-01-2026
NEXGEL, INC. filed an 8-K on 2026-01-30 disclosing officer or director changes under Item 5.02, which covers departures, elections, appointments, or compensatory arrangements of certain officers. Item 9.01 references attached financial statements and exhibits. No specific details on positions affected, individuals, reasons, timing, or compensation are disclosed.
30-01-2026
urban-gro, Inc. filed an 8-K on January 30, 2026, under Item 5.02 disclosing departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements, alongside Item 5.07 on submission of matters to a vote of security holders and Item 9.01 for financial statements and exhibits. No specific details on positions affected, reasons for changes, vote outcomes, or exhibit contents are disclosed. No quantitative financial metrics, performance comparisons, or directional indicators provided.
30-01-2026
Ondas Holdings Inc. filed an 8-K on 2026-01-30 disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), with Item 9.01 listing Financial Statements and Exhibits. No specific details on the key position affected, appointment or resignation status, reasons, timing, or individuals involved are provided. No quantitative financial metrics, performance comparisons, or governance impacts are mentioned.
Get daily alerts with 12 investment signals, 10 risk alerts, 8 opportunities and full AI analysis of all 39 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Corporate Distress Financial Stress SEC Filings — March 24, 2026
US Corporate Distress Financial Stress SEC Filings